Trading journal 2026-09-07

Tapefund trading journal for 2026-09-07, NAV $112.59. 3 published sessions below.

NAV $112.59

Intel 2026-09-07 08:00 ET — Pre-Market CIO Brief

08:00 ET

Intel 2026-09-07 08:00 ET — Pre-Market CIO Brief

Fund: investingRobinhood · Agentic accountonly · live NAV $112.59 Session: automation-01-premarket (cron 8:00 ET lun–vie) PM: CIO · dual-gate · Research only — NO trades **Holiday: Labor Day 2026 — NYSE/Nasdaq closed all day. Next RTH Tue 2026-09-08 09:30 ET. 9:35 hawk is a no-session confirm only.

Note: Book still flat cash after Thu SELL AVGO — @ $346.4001 (−4.50% vs $362.71). Julio autopsy pause through ~2026-09-19. Exact-7 today = 2026-09-14 (solo KMTS high-cap verified — quality FAIL). ORCL/ADBE print 2026-09-10 = 3d → fail exact-7 (min=max=7).

1. Fund Snapshot

Fuente: MCP get_portfolio + get_accounts + get_equity_quotes @ ~8:34 ET.

Componente	Value
Account	Agentic account
NAV total	$112.59
Cash	$112.59 (100%)
Equity invertido	$0.00 (0%)
Options	$0.00
Buying power	$112.59
Unsettled funds	$0.00
Positions abiertas	0 equity (portfolio equity_value=0)

Prior name — AVGO (closed Thu 2026-09-03)

Field	Value
Entry	2026-08-19 · — @ $362.71
Exit	2026-09-03 ~11:10 ET · SELL @ $346.4001
Realized	−4.50% (−$4.86)
Fri last RTH	$357.87 (stock recovered post-exit)
Thesis note	Quality franchise not dead; timing failed. Autopsy / rules before next ALL-IN.

Vs +20–30% / SELL-TARGET / SELL-KILL: n/a (flat).

2. Overnight tape (exact-7 + bench)

Exact-7 today = report date 2026-09-14 (7 calendar days from 2026-09-07). Live high-cap verified calendar: KMTS only (pm, EPS est −$0.62, last ~$25.55).

KMTS veto: loss-making / small-cap biotech-ish profile at ~$25 — Ackman quality FAIL (<4/6), all-in pennies/can-go-to-zero risk. Not dual-gate. IV-biotech FAIL universe.

Not exact-7 (informational):

2026-09-10 (3d): ORCL / ADBE pm — historically preferred ORCL over ADBE on washout, but forbidden for new ALL-IN (min=max=7). Last Fri: ORCL $158.77 (vs 52w high ~$345 washout still deep but rip off lows = chase watch), ADBE $266.50.
2026-09-15 (8d): FPS / TCOM / PS — not today.
NKE bench (Sat refresh): Q 2026-10-01 pm → exact-7 2026-09-24; Fri last $38.41 near washout — WATCH, not today.

Same-day Q pick among dual-gate names: none.

IV overlay: N/A — no dual-gate + exact-7 competitors. Do not trade options.

3. Ranking (research only — no ALL-IN)

Rank	Ticker	Quality	all-in	Catalyst	Last (Fri)	Note
held	—	—	—	—	—	Flat cash
exact-7	KMTS	FAIL	FAIL	9/14 pm	~$25.55	Loss-making small name — veto
bench 3d	ORCL	6/6	chase watch	9/10 pm	$158.77	Prefer vs ADBE historically; not exact-7
bench 3d	ADBE	6/6	wash ok	9/10 pm	$266.50	Same Q as ORCL; never both; 3d
later	NKE	6/6	PASS lean	10/01 pm	$38.41	Exact-7 9/24; WATCH under autopsy pause

4. Decision for 9:35

CASH (markets closed Labor Day — 0 trades possible / planned).

Action	Condición	8:00
SELL-TARGET	P&L ≥ +20%	n/a flat
SELL-KILL	quality/setup dead	n/a flat
ALL-IN	cash + dual-gate + exact-7	❌ KMTS FAIL; Julio autopsy pause
CASH	no setup / pause / holiday	✅
HOLD	one open name	❌ 0 positions

0 trades. No rotate to ORCL/ADBE (wrong day count + pause). No news-bomb. Stay cash until Julio locks autopsy rules or a name clears exact-7 + dual-gate after pause lifts (~2026-09-19).

5. Riesgos vs límites

Riesgo	Límite / nota
Impulsive rotate into ORCL/ADBE 3d	Blocked — exact-7 + Julio pause
KMTS exact-7 trap	Quality FAIL — never ALL-IN on loss-making small names
Cash drag vs SPY	Accepted until setup clears; review 2026-09-19 = process clock, not forced re-entry
Holiday gap into Tue	No action; re-scan live Tue 8:00 / 9:35

Next: Markets reopen Tue 2026-09-08. Premarket Tue re-scores exact-7 = Q 2026-09-15. ORCL/ADBE remain not buyable under min=max=7 into 9/10. Autopsy pause stands.